Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has announcements × Prostatic Neoplasms × apalutamide × Clear all

Phase

Status

Active not recruiting 2

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

enzalutamide 2 apalutamide 2 Pluvicto 2 Leuprolide 2 Androgen Antagonists 2 relugolix 1 luprolide acetate gel depot 1 gallium 68 PSMA-11 1 Prednisone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01946204 2026-02-02

SPARTAN

Aragon Pharmaceuticals, Inc.

Phase 3 Active not recruiting

1,207 enrolled 15 charts 1 FDA

Prostatic Neoplasms

NCT02489318 2026-02-02

TITAN

Aragon Pharmaceuticals, Inc.

Phase 3 Active not recruiting

1,052 enrolled 13 charts 1 FDA

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡